Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Raza_Bokhari
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
development of therapeutics for cancer
|
| gptkbp:founded |
1981
|
| gptkbp:has_research_area |
oncology
rare diseases |
| gptkbp:headquarters_location |
gptkb:Piscataway,_New_Jersey,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Adagen
gptkb:PEG-Intron |
| gptkbp:specializesIn |
PEGylation technology
|
| gptkbp:stockSymbol |
gptkb:ENZN
|
| gptkbp:subsidiary |
gptkb:Enzon,_Inc.
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
http://www.enzon.com/
|
| gptkbp:bfsParent |
gptkb:Carl_Icahn
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Enzon Pharmaceuticals
|